Pancreas islet xenografts but not allografts are resistant to autoimmune disease recurrence following islet transplantation.
Thomas
F T
FT
Department of Surgery, University of Alabama at Birmingham 35294-0016, USA.
Pittman
K
K
Brezina
P
P
Wu
J
J
Mountz
J
J
Contreras
J
J
Thomas
J
J
Berzina
P
P
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000628:therapy*; D005260:Female; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D051379:Mice; D016688:Mice, Inbred NOD; D011817:Rabbits; D012008:Recurrence; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus